MedPath

A study on the effectiveness and efficiency of the NiceDay Smartphone Application in psychiatric patients with unipolar depressio

Withdrawn
Conditions
Depression
mood disorder
10027946
Registration Number
NL-OMON47460
Lead Sponsor
Parnassia Bavo Groep (Den Haag)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Withdrawn
Sex
Not specified
Target Recruitment
187
Inclusion Criteria

18-65 years old
Unipolar moderate-severe depression according to DSM-5 and MINI-PLUS
In possession of a Smartphone
Proposed treatment = Pharmacotherapy with CBT

Exclusion Criteria

Insufficient command of the Dutch language
Insufficient command of the Smartphone
Comorbidity: Severe psychiatric disorders (personality disorders Axis II,
addiction/intoxication)
Comorbidity: Severe medical conditions and physical disorders (Axis III)
Comorbidity: Severe psychosocial and environmental problems (Axis IV)
Use of medication that interferes with the use of NiceDay (severe sedatives for
example)
Change of medication during treatment with behavioral activation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The most important outcome measure of this study is *Speed of remission *,<br /><br>which is a measure of the speed with wich symptom reduction takes place as a<br /><br>result of the intervention. It is expressed a sthe area unbder teh curve that<br /><br>described symptom scores (on a depresison rating scale) versus time. Since the<br /><br>costs of the applied interventions are known at the level of minutes, it is<br /><br>possible to calculate the cost-effectiveness (efficiency) of NiceDay versus<br /><br>behavioral treatment as usual.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Apart from psychometrics, we measure Quality Of Life and (to a limited extent)<br /><br>physical health parameters.</p><br>
© Copyright 2025. All Rights Reserved by MedPath